Eledon pharmaceuticals announces participation in november conferences

Irvine, calif., nov. 04, 2021 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (als), today announced that members of management will be participating in two upcoming virtual investor conferences in november.
ELDN Ratings Summary
ELDN Quant Ranking